Follow-up study shows that exercise may improve PFS in lymphoma patients

the ONA take:

Many studies have previously shown the benefits of exercise for patients with cancer, but few randomized, controlled trials have examined survival outcomes resulting from aerobic exercise. In a recent report published in Cancer Causes and Control, researchers performed an exploratory follow-up of progression –free survival (PFS) from the Healthy Exercise for Lymphoma Patients (HELP) trial. The HELP trial randomly assigned 122 patients between 2005 and 2008 to either control or 12 weeks of supervised aerobic exercise. In addition, the control group patients were offered a 1-month crossover of supervised exercise (12 sessions) after post-intervention assessments (about 4 months after randomization). When the three groups were analyzed after the trial was closed, the group that received supervised exercise had a 5-year PFS of  68.5 % compared with 59.0 % for the group that received no supervised exercise (HR 0.70, 95 % CI 0.35–1.39,p = 0.31). Although the HELP study was not designed to evaluate the impact of exercise on survival outcomes, and there was no evidence that random assignment to 12 weeks of supervised exercise has an effect on the PFS of lymphoma patients, the results do provide a basis for exploring this topic in larger studies in the future.

Follow-up study shows that exercise may improve PFS in lymphoma patients
Follow-up study shows that exercise may improve PFS in lymphoma patients
The authors report an exploratory follow-up of progression-free survival (PFS) from the Healthy Exercise for Lymphoma Patients (HELP) Trial. This exploratory follow-up of the HELP Trial suggests that supervised aerobic exercise may be associated with improved PFS in lymphoma patients. Larger trials designed to answer this question are needed.
READ FULL ARTICLE From Mdlinx
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs